New Eye Drops Show Promise in Treating Age-Related Farsightedness
As people grow older, many face a common vision issue called presbyopia, which makes it difficult to focus on close objects. Typically, this leads to the use of reading glasses. However, recent research indicates that a new treatment may provide an alternative way to improve close-up vision.
A study presented at the recent Congress of the European Society of Cataract and Refractive Surgeons in Denmark revealed that specially designed eye drops could help restore near vision for many individuals, circumventing the need for glasses or surgery.
The research involved 766 patients, predominantly in their mid-50s, who were experiencing the typical effects of presbyopia. Instead of prescribing glasses, researchers provided eye drops containing pilocarpine—a drug that assists the eye in focusing—paired with diclofenac, a mild anti-inflammatory to enhance comfort during application.
Dr. Giovanna Benozzi, who leads the Center for Advanced Research for Presbyopia in Buenos Aires, Argentina, explained that this study was motivated by the need for better solutions for managing presbyopia. “Current options, such as reading glasses or surgical procedures, have their drawbacks, including inconvenience and potential risks,” she noted.
Participants in the study were instructed to apply the drops twice a day, with the chance for a third application if needed. Their progress was monitored over two years using small-print eye charts.
Remarkably, within just an hour of the initial dose, many patients noticed they could read significantly more lines on near-vision tests. In the lowest concentration group, nearly all participants could see at least two extra lines, while stronger concentrations helped many read three or more.
After a year using these drops, over 80% of participants still enjoyed improved near vision without glasses, and many reported the benefits lasted even longer. While some side effects occurred—like temporary dimming of vision or mild irritation—none of the participants stopped using the drops.
Dr. Benozzi stated that these eye drops won’t replace surgical options for those wishing for a permanent fix, but they could provide an easy, non-invasive alternative. “This gives patients more options, reducing reliance on their reading glasses,” she added.
Despite the eye drops showing promise, experts caution that further research is needed before they become widely available. The study took place in a single location, which raises questions about how the results might apply to broader populations.
While pilocarpine has a long history of use in other eye therapies, experts are mindful of potential long-term effects from daily use. They also recommend additional scrutiny of diclofenac’s prolonged effects on the eye’s surface.
Overall, while the findings are encouraging, researchers advocate for larger, multi-center studies to validate the results and ensure safety over the long term.
